Emily R. York

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Emily R. York is an author at University of Colorado Denver specializing in oncogenic signaling pathways, molecular oncology, and lung cancer pharmacotherapy.

ORCID

Publications per year

2017–2018

Publications

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR- Mutant Non–Small Cell Lung Cancer

Emily R. York, Marileila Varella‐Garcia, Tami J. Bang et al. · Journal of Thoracic Oncology · 2017 · 75 citations · Full text

Medicine, Oncology, Pharmacology +15

Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib

Terry L. Ng, Hui Yu, Derek Smith et al. · Clinical Lung Cancer · 2018 · 19 citations

Medicine, Genetics, Oncology +12

1–2 of 2